相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms of drug resistance in ovarian cancer
Steven W. Johnson et al.
CANCER (2010)
Clinicopathological characteristics of mucinous adenocarcinoma of the ovary
Muneaki Shimada et al.
GYNECOLOGIC ONCOLOGY (2009)
Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: Results of a single-institutional phase II study
Heeseok Kang et al.
GYNECOLOGIC ONCOLOGY (2009)
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
Hiroaki Itamochi et al.
CANCER SCIENCE (2008)
Mechanisms of platinum drug resistance
M Ohmichi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin
E Arimoto-Ishida et al.
ENDOCRINOLOGY (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel
S Mabuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
A phase I/II study of topotecan in combination with carboplatin in recurrent epithelial ovarian cancer
G Bolis et al.
GYNECOLOGIC ONCOLOGY (2001)
分享论文
